BELGIUM LUXEMBOURG BELGIUM LUXEMBOURG ALUMNI SIGN UP Search form SEARCH Elixir of the afterlife Predicting post-exclusivity market situations for medicines past midpoint of the product lifecycle November 2021 Healthcare & life sciences Executive summary There is no such thing as eternal exclusivity for medicines. All medicines eventually lose exclusivity and become open to competition from generic or biosimilar alternatives. Loss of exclusivity (LOE) occurs when the period of patent protection and any prohibiting instruments are no longer in effect. The post-LOE market can be tranquil, choppy, or stormy for proprietary medicines. To gauge what the future holds after LOE, pharmaceutical companies must carry out a market prediction using the post-LOE market prediction model. Foreknowledge of the post-LOE market will enable the proprietary firm to determine what LOE strategy to pursue to maximize value from the medication. Download full report This report was written by: < PREVIOUS Copper switch off: Opportunity to drive infrastructure convergence? How to successfully manage the migration from copper to future-proof technologies NEXT > The insight: how Europe’s private equity industry is anchoring long-term investors Pan-European market sentiment survey Follow us Admin Legal information Cookie Policy Notice of Privacy This site uses cookies and gives you control over what you want to activate OK, accept all Deny all cookies Personalize Privacy policy